(950/0 confidence interval 14% to 20%) for all stroke types (115/675), 18% (15% to 21%) for cerebral infarction (97/545), 11% (4% to 11%) for primary intercerebral haemorrhage (7/66) , and 00/0 (0 to 1l%) for subarachnoid haemorrhage (0/33). For patients with cerebral infarction the 30 day case fatality rate was significantly higher with atrial fibrillation (23%) than with sinus rhythm (8%); the risk of early recurrent stroke (within 30 days) was 1% with atrial fibrillation and 4% with sinus rhythm. In patients who survived at least 30 days the average annual risk of recurrent stroke was 8.2% (5-9% to 10 /9%) with sinus rhythm and 11% (6.0% to 17.3%) with atrial fibrillation.
Conclusions-After a first stroke atrial fibrillation was not associated with a definite excess risk of recurrent stroke, either within 30 days or within the first few years. Survivors with and without atrial fibrillation had a clinically important absolute risk of further serious vascular events.
Introduction
People with atrial fibrillation have an increased risk of stroke compared with people with sinus rhythm'-10; if the arrhythmia is not associated with valvar heart disease the increase in risk may be only slight4 0°" or even non-existent. 8 Primary prevention of stroke has been studied in several randomised trials in patients with atrial fibrillation, the results suggesting that a 3-6% annual risk of stroke can be reduced by at least 20-40% with anticoagulant or antiplatelet treatment.'2-14 Once a stroke has occurred it is not clear whether the subsequent early and long term risks of death or recurrent stroke are significantly different in patients with and without atrial fibrillation. Some studies have suggested that atrial fibrillation is associated with an increased risk of death in the first four weeks after a stroke'5 16 whereas another has not.2 Similarly, some studies have suggested substantially higher early and long term risk of recurrent stroke in patients with atrial fibrillation compared with sinus rhythm'7-'9 whereas others suggested little if any difference.220 The aim of this study was to determine the contribution of atrial fibrillation to the causation of different types of stroke and to the early and long term risks of death and recurrent stroke after a first stroke, thereby identifying priorities in the early and long term management of patients with stroke and atrial fibrillation. A study of prognosis should satisfy certain methodological criteria.2' The Oxfordshire community stroke project satisfies most, if not all, of these criteria.2223
Patients and methods
The methods used in the Oxfordshire community stroke project and the characteristics of the cohort of patients with stroke have been described elsewhere.--Briefly, it was a prospective community based register of all new cases of acute cerebrovascular disease, including cases of stroke and transient ischaemic attack, occurring in a defined population of about 105 000 residents of Oxfordshire. Meticulous case ascertainment methods were used to detect cases whether patients were admitted to hospital, managed at home, or treated elsewhere while temporarily resident outside Oxfordshire. All patients were seen as soon after the event as possible by one of the neurologists on the study (PS, JB, MD, JB, or CW) and basic investigations including electrocardiography, chest radiography, and computed tomography were performed. If computed tomography could not be performed and the patient died every effort was made to obtain a necropsy to determine the pathological type of stroke. The classification and definitions of the different pathological types of stroke are detailed elsewhere. '223 We included only patients with their first ever stroke. Detailed definitions of the subtypes of cerebral infarction are given elsewhere. '425 Definition of atrialfibrillation The diagnosis of atrial fibrillation must (a) have been confirmed by an electrocardiogram showing either absent p waves or atrial flutter with an irregular ventricular response and (b) have been documented before the stroke, at the time of assessment by the project team, or within one month after the onset of the first stroke. Patients first found to have atrial fibrillation more than one month after the stroke who did not have atrial fibrillation at the time of the stroke or before were classified as having sinus rhythm. Ambulatory monitoring of electrocardiograms was not routinely performed.
Follow up-Two research nurses followed up the patients at one month, six months, one year, and annually thereafter. Patients who left the area were traced through their general practitioner. The final follow up examination of all survivors irrespective of their area of residence was performed by one of the study neurologists between August 1987 and October 1988.
Recurretnt stroke and vascular death-All patients with suspected recurrent stroke were re-examined by one of the study neurologists as soon after the event as possible; the clinical data on all such events were then reviewed at regular consensus meetings of the study team. At the final follow up examination by the neurologist all medical records (including the general practitioners') that related to any suspected recurrent stroke were reviewed. Events were then classified as a definite recurrence if there was clear clinical evidence of the sudden onset of a new neurological deficit, or an increase in an existing deficit, for which no explanation other than a recurrent stroke could be found. Vascular death included deaths due to either the initial or recurrent stroke as well as sudden and unexplained death, sudden death presumed to have cardiac causes, death associated with cardiac disease, and death due to other vascular causes-for example, a ruptured aortic aneurysm. We planned analyses of survival in patients with cerebral infarction and in patients who survived at least 30 days after the first stroke.
Statistical miethods Confidence intervals for proportions, odds ratios, and differences of proportions were estimated using standard methods26 27; odds ratios were adjusted using log linear modelling. p Values for two by two contingency tables were calculated from the x2 statistic, or from Fisher's exact test27 when one or more expected cell frequencies were less than 5. For tables with more cells the Mantel-Haenszel procedure was used to calculate a summary statistic and derive the odds ratio. The mean ages of patients with atrial fibrillation and sinus rhythm were 77 (SD 8 8) and 70-6 (13 7) years respectively; the difference was significant (p < 0 0001). The prevalence of vascular risk factors, of clinical evidence of large artery disease, and of valvar heart disease associated with atrial fibrillation is given in table II. Thyroid function was not systematically measured in all patients, but review of medical records in a subsample (a consecutive series of the first 323 cases of first stroke registered by the Oxfordshire community stroke project) showed that only one of the 46 patients with atrial fibrillation (2% (95% confidence interval 0 to 6%)) had thyrotoxicosis.
USE OF ANTIPLATEILET AND ANTICOAGUIANT TREATMENT
Before stroke Twenty nine of the 675 patients (43/ 3%) and 1 1 of the 1 5 (9. 6%) patients with atrial fibrillation were receiving antiplatelet treatment when the stroke occurred. Seven of the 675 (1 -0%) patients and four of the 1 15 (3 5%) patients with atrial fibrillation were taking oral anticoagulants when the stroke occurred.
After stroke-Antiplatelet and anticoagulant treatment were not used systematically after stroke. Of the 97 patients with atrial fibrillation and cerebral infarction, 21 received anticoagulant and 16 antiplatelet treatment at some time after the stroke; few of them were given long term maintenance treatment.
CASE FATALITY RATES AT 30 DAYS
In general, the case fatality rates at 30 days were significantly higher in patients with atrial fibrillation (table III) ; the twofold or threefold differences were not significant for all subgroups. The differences were significant for all stroke types combined and in patients with cerebral infarction. In patients with cerebral infarction the case fatality rates at 30 days were 23% (14.8% to 32.3%) in those with atrial fibrillation (table IV, fig 1) . There was no significant excess of recurrent stroke in patients with atrial fibrillation (table IV, fig 2) .
Unadjusted analyses in survivors offirst cerebral infarction at 30 days-There was a significant excess of deaths from all causes in patients with atrial fibrillation, but no excess risk of vascular death, of recurrent stroke, or of recurrent stroke or vascular death (table IV, fig 3) .
Average annual risks-The average annual risks of vascular events are given in table V. The excess observed in patients with atrial fibrillation was not significant and, because of the small number of events, the confidence intervals were wide. Our study had sufficient power to exclude large differences in the long term risk of serious vascular events between patients BMJ VOLUME 305
with atrial fibrillation and those with sinus rhythm, but we cannot exclude small differences in absolute risks; the confidence intervals include the possibilities that average annual risks might be 2-3% lower or, equally, that they are 9-12% higher in patients with atrial fibrillation compared with patients with sinus rhythm. Proportionzal hazards analysis Patients with atrial fibrillation had a higher mean age than those with sinus rhythm and were more likely to have large cerebral infarcts (table I). As age and subtype of cerebral infarction were highly significant predictors of long term outcome, we used Cox's proportional hazards model3" to determine the independent effect of atrial fibrillation on survival beyond 30 days (table VI) . Allowing for these factors reduced the differences between the atrial fibrillation and sinus rhythm groups, and the only outcome showing a significant difference was death from all causes. Thus, although our data suggest that atrial fibrillation is an independent predictor of death in the early phase of stroke, it is not an independent predictor of early or late recurrence of stroke or of vascular death in the long term; it is a weak predictor of death from all causes in the long term.
EFFECT OF VALVAR HEART DISEASE ON OU I'COME To see whether the presence or absence of valvar heart disease in patients with atrial fibrillation and sinus rhythm influenced outcome, we performed unadjusted log rank and Cox's regression analyses (adjusting for age and stroke type) on the short and long term risk of stroke, death from stroke or vascular death, vascular death, and death from all causes.
The number of patients with valvar heart disease was small, but the presence or absence of valvar heart disease did not significantly affect the outcomes studied.
Discussion
It is important to determine the role of atrial fibrillation in the pathogenesis and on the prognosis of a first stroke and on the long term risks of recurrent stroke and vascular death. If a major excess risk of vascular occlusive events (as seen in symptom free people with atrial fibrillation) persists in survivors of stroke such patients require special attention as a high risk group for secondary prevention. If, on the other hand, there is little difference in risk between having atrial fibrillation and sinus rhythm after a stroke then efforts at secondary prevention do not need to be focused on patients with atrial fibrillation.
PROGNOSIS OR UNTREATED NATURAI COURSE?
Many of the patients in this series were known to have had atrial fibrillation before the stroke occurred, though only a few had been taking anticoagulants and very few continued to receive anticoagulant or antiplatelet treatment after their stroke; if they did many did not receive long term maintenance treatment. Our results do not therefore represent a study of the natural course of stroke in a group of untreated patients, rather a study of prognosis in a group not treated aggressively. Any relative differences in prognosis in patients with and without atrial fibrillation are unlikely to be due to the use (or lack of use) of treatment in one group. Though limited use of antithrombotic and other treatments may have reduced the absolute risk of recurrent vascular events to some extent in both patients with atrial fibrillation and those with sinus rhythm, we think that any difference in absolute risk between the patients in our study and a completely untreated group would probably not be large. The Oxfordshire community stroke project therefore provides a representative sample of patients generally not treated with anticoagulants in whom the effect of atrial fibrillation on prognosis after a stroke can be examined.
METHODOLOGICAL STRENGTHS AND WEAKNESSES IN 'HIS AND PREVIOUS STUDIES
There have been several studies on atrial fibrillation and the risk of ischaemic stroke2 13"20 31. Our study satisfied (but not perfectly) the criteria for a methodologically sound prognostic study: 675 cases were followed without loss for up to six years, the sample was representative of all strokes in the community and not just those admitted to hospital, patients entered the study at any early stage of the natural course of the disease (with their first ever stroke) soon after its onset, the pathological type of the initial stroke was verified in over 90% of cases, the assessment of outcome events was prospective and as blind to the hypothesis under test as was practicable (since many hypotheses were being examined simultaneously). There were, however, some methodological weaknesses in our study. As this was a community based study we aimed to perform only the essential investigations on every patient. We did not have the resources to undertake detailed cerebral, cardiac, or arterial imaging and function studies as in some hospital based studies 3 42 .4'; we may therefore have underestimated the prevalence of certain cardiac disorders.
FREQUENCY OF ATRIAL FIBRILLAT1'ION IN PATIEN-IS WITH DIFFERENT TYPES OF CEREBROVASCULAR LESIONS
The frequency of atrial fibrillation in our sample of patients with first strokes is similar to that in previous community studies3 "'L 42 and some of the large hospital based stroke registers4549 but lower than in a hospital case series of hemiplegic strokes6 and a hospital registry of stroke in patients aged over 60. 5 
A maximum of only two of the seven cases could have been due to an arrhythmia as a result of the stress of the acute event; this is a small piece of evidence to support the notion that, in some strokes, the presence of atrial fibrillation is merely coincidental.
These data also highlight the importance of performing computed tomography early to exclude intracerebral haemorrhage in every patient with stroke and atrial fibrillation, before anticoagulants are given.
Of greater importance is the prevalence of atrial fibrillation in different subtypes of cerebral infarction. As anticipated, it is highest in patients with large infarcts presumed to be due to occlusion of the main stem of the middle cerebral artery (total anterior circulation infarction) and lowest in patients with lacunar infarction. In patients with lacunar infarction it is interesting to speculate whether the atrial fibrillation was the cause of the stroke or merely a marker of coincidental atherosclerotic cardiac disease. One other comparable community based stroke register has used a similar classification of cerebral infarction, and the prevalence of atrial fibrillation in the different subgroups was remarkably similar to our results.4' Other groups have noted the association of atrial fibrillation with clinically large cortical infarcts'3 46 AS and angiographically proved occlusion of the middle cerebral artery2 and that a small proportion of patients with lacunar infarctions have atrial fibrillation.394' 42 46 48 5 In our series patients in atrial fibrillation often had other risk factors for cerebral infarction (table II) . Thus, in a particular patient several potential causes for stroke may be present. Therefore, although some strokes in patients with atrial fibrillation are due to large cerebral infarcts presumed to be due to embolism from the heart, many must be caused by other mechanisms: primary intracerebral haemorrhage, atheroembolism from neck arteries, and occlusive small vessel disease of the intracranial perforating arteries. The exact proportion of non-cardioembolic strokes is unclear.
In the Oxfordshire community stroke project the prevalence of atrial fibrillation in patients with transient ischaemic attacks and those with ischaemic stroke was similar (14% and 18% respectively). This contrasts with the results from a tertiary referral centre where the overall prevalence of atrial fibrillation was lower and atrial fibrillation much higher in patients with stroke than in patients with transient ischaemic attacks ( likely to have diabetes mellitus, valvar heart disease, and mitral stenosis. On the other hand, cervical bruits (from the carotid or subclavian artery) were less common in patients with atrial fibrillation. The prevalence of hypertension and other markers of vascular disease (ischaemic heart disease and peripheral vascular disease) were similar in patients with atrial fibrillation and sinus rhythm. In our sample most cases of atrial fibrillation were not associated with rheumatic mitral stenosis and 74% were not associated with any form of valvar heart disease. As a recent review has suggested that the excess risk of stroke in thyrotoxic atrial fibrillation may be small,5' our inability to determine precisely the proportion of cases associated with thyrotoxicosis is probably unimportant.
EARLY PROGNOSIS: RISK OF DEATH WITHIN 30 DAYS
Atrial fibrillation was clearly associated with an increased risk of death within 30 days of stroke (p=0O00003). Most of this excess was explained by the association of atrial fibrillation with large infarcts and by the older age of patients with atrial fibrillation, but a small excess risk persisted after adjustment for these factors. Others have found an increased early case fatality in atrial fibrillation'3 I 1 ' ' 5' and related it to the size of infarct'54' and to packed cell volume.'6 One plausible explanation for the increased early case fatality might be a high early risk of recurrent stroke in atrial fibrillation which has been reported by some groups'7 31 33 but has not been confirmed by others. '5 9 We observed a lower risk of early recurrence in patients with atrial fibrillation, so the excess risk of early death associated with atrial fibrillation cannot be accounted for by recurrences in our series.
Another possibility for the excess mortality (not accounted for by infarct size and the patients' age) might be diabetes49; hyperglycaemia is an adverse prognostic factor in acute stroke. Detailed multiple regression analyses of all possible prognostic factors in acute stroke will be reported separately.
EARLY PROGNOSIS: RISK OF EARLY RECURRENT STROKE
In this series the risk of early recurrence was low in all patients with cerebral infarction and was lower than the risk found in some early studies'7 1'35 37 50 but comparable to that in some recent studies. 2 5 3-46 This low risk is unlikely to be due to early treatment with antiplatelet or anticoagulant drugs.
The reason for the low early risk in recent studies might be because of differences in methods. Patients in our study were not monitored daily and we may have failed to detect some early recurrences. In addition, differing definitions of recurrent stroke in different studies could account for some of the differences. On the other hand, in our study at least it is unlikely that there was differential ascertainment of recurrences in patients with and without atrial fibrillation; thus our estimate of the relative difference of recurrence between patients with atrial fibrillation and those with sinus rhythm is likely to be unbiased even if we have underestimated the absolute risk of early recurrence. Detailed discussion is not warranted because the number of events was so small. (table IV) . However, much of the difference is due to the high early death rate from atrial fibrillation described above. The similarity in the risk of recurrent stroke in the Oxfordshire community stroke project in patients with atrial fibrillation and sinus rhythm is quite striking. The absolute risk of recurrent strokes in people who survived 30 days expressed as an average annual risk is similar to that reported by Marquardsen (for males in Marquardsen's study, the average annual risk was 14% in patients with atrial fibrillation and 8-5% in those with sinus rhythm). 20 The stroke data bank study found two year recurrence risks for patients with first stroke of 121 -% and 999% for those with sinus rhythm and atrial fibrillation respectively. 46 Marquardsen's series may have had a worse prognosis than the other two studies because it consisted of a hospital based cohort of patients with more severe strokes in whom management of risk factors was probably not intensive. 20 The Framingham study reported a non-significant trend towards early recurrence in patients with stroke and atrial fibrillation,2 but average annual life table risks of recurrence were not reported (crude cumulative totals were not significantly different (atrial fibrillation 25%, sinus rhythm 20%)).
Furthermore, in the Oxfordshire community stroke project, analysis of long term survival among patients who survived at least 30 days showed that although, in unadjusted analysis, death from all causes occurred significantly more often in patients with atrial fibrillation (table IV) , multiple regression analyses, adjusting for the older average age and the larger cerebral infarcts among patients with atrial fibrillation, showed that none of these events occurred significantly more frequently with atrial fibrillation than with sinus rhythm. Of course, the lack of any relative difference between atrial fibrillation and sinus rhythm (with respect to long term outcome at least in this community study and in that of the stroke data bank)46 emphasises that both atrial fibrillation and sinus rhythm have a relatively high absolute risk of recurrent stroke and vascular death46; attention to secondary prevention measures after stroke should not be overemphasised in patients with atrial fibrillation at the expense of those with sinus rhythm.
